hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance.
Lastraioli E, Lottini T, Iorio J, Freschi G, Fazi M, Duranti C, Carraresi L, Messerini L, Taddei A, Ringressi MN, Salemme M, Villanacci V, Vindigni C, Tomezzoli A, La Mendola R, Bencivenga M, Compagnoni B, Chiudinelli M, Saragoni L, Manzi I, De Manzoni G, Bechi P, Boni L, Arcangeli A.
Lastraioli E, et al. Among authors: iorio j.
Oncotarget. 2016 Sep 13;7(37):59535-59547. doi: 10.18632/oncotarget.11149.
Oncotarget. 2016.
PMID: 27517748
Free PMC article.